Stock Comparison
HLN vs RDY
Haleon plc and Dr. Reddy’s Laboratories Ltd ADR side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$40.72B
$12.81B
P/E (TTM)
18.9
28.5
Forward P/E
17.5
28.5
Price/Sales
3.7
0.0
Price/Book
1.9
3.2
EV/EBITDA
13.3
14.1
Dividend Yield
2.09%
0.54%
Profitability
Net Margin
15.10%
12.80%
Operating Margin
23.20%
1.54%
Return on Equity
10.30%
11.80%
Return on Assets
4.67%
5.74%
Growth (YoY)
Revenue Growth
0.60%
-11.60%
Earnings Growth
92.00%
-86.20%
Price & Risk
Beta
0.2
0.3
52-Week High
$11.13
$15.67
52-Week Low
$8.60
$12.19
Analyst Target
$11.69
$14.31
Compare HLN and RDY your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.